GlassScriptPhysician profile
Kenneth B Kummerfeld
NPI 1861487274
$1,083.81
in general payments reported to CMS, 2019-2025
13 companies · $16.11 in 2025
The $16.11 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2021: $163 · 2022: $28.84 · 2023: $526 · 2024: $176 · 2025: $16.11.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $278.21 | 2021-2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.19 | 2023-2025 | Lifevest |
| Abbott Laboratories | $131.09 | 2023 | Mitraclip |
| Medtronic Vascular, INC. | $112.00 | 2019 | |
| Merck Sharp & Dohme LLC | $79.56 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $48.95 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $48.50 | 2022-2023 | Camzyos |
| Sanofi-Aventis U.S. LLC | $37.73 | 2019-2024 | |
| Pharmacyclics LLC, An Abbvie Company | $33.96 | 2023 | Imbruvica |
| Irhythm Technologies, INC. | $32.55 | 2019-2021 | |
| Boston Scientific Corporation | $27.54 | 2024 | Watchman Flx |
| Lexicon Pharmaceuticals, INC. | $14.89 | 2024 | |
| Pfizer INC. | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kummerfeld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.